NAMPT and Neonatal sepsis: Interesting findings obtained from smaller trials demonstrated elevated visfatin serum levels in patients with respiratory diseases [12–14] and neonatal sepsis [15] as well as in patients with severe trauma or with critical neurological diseases [2].